Literature DB >> 18049372

Cytotoxicity is predicted by unbound and not total bilirubin concentration.

Sebastián D Calligaris1, Cristina Bellarosa, Pablo Giraudi, Richard P Wennberg, J Donald Ostrow, Claudio Tiribelli.   

Abstract

Although it has been suggested that the unbound, free, (B(f)) rather than total (B(T)) bilirubin level correlates with cell toxicity, direct experimental evidence supporting this conclusion is limited. In addition, previous studies never included a direct measurement of B(f), using newer, accurate methods. To test "the free bilirubin hypothesis", in vitro cytotoxicity was assessed in four cell lines exposed to different B(f) concentrations obtained by varying B(T)/Albumin ratio, using serum albumins with different binding affinities, and/or displacing unconjugated bilirubin (UCB) from albumin with a sulphonamide. B(f) was assessed by the modified, minimally diluted peroxidase method. Cytotoxicity varied among cell lines but was invariably related to B(f) and not B(T). Light exposure decreased toxicity parallel to a decrease in B(f). In the absence of albumin, no cytotoxicity was found at a B(f) of 150 nM whereas in the presence of albumin a similar B(f) resulted in a 40% reduction of viability indicating the importance of total cellular uptake of UCB in eliciting toxic effect. In the presence of albumin-bound UCB, bilirubin-induced cytotoxicity in a given cell line is accurately predicted by B(f) irrespective of the source and concentration of albumin, or total bilirubin level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049372     DOI: 10.1203/PDR.0b013e3181568c94

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

1.  Effect of storage and freezing on unbound bilirubin measurement.

Authors:  Sanjiv B Amin; Charles Ahlfors
Journal:  Clin Chim Acta       Date:  2008-06-30       Impact factor: 3.786

2.  Intravenous lipid and bilirubin-albumin binding variables in premature infants.

Authors:  Sanjiv B Amin; Theresa Harte; Lori Scholer; Hongyue Wang
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

Review 3.  Newborn jaundice technologies: unbound bilirubin and bilirubin binding capacity in neonates.

Authors:  Sanjiv B Amin; Angelo A Lamola
Journal:  Semin Perinatol       Date:  2011-06       Impact factor: 3.300

Review 4.  Bilirubin Binding Capacity in the Preterm Neonate.

Authors:  Sanjiv B Amin
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

5.  Effect of ibuprofen on bilirubin-albumin binding affinity in premature infants.

Authors:  Sanjiv B Amin; Nicholas Miravalle
Journal:  J Perinat Med       Date:  2010-10-18       Impact factor: 1.901

6.  Effect of bilirubin on cytochrome c oxidase activity of mitochondria from mouse brain and liver.

Authors:  Safarina G Malik; K Astrid Irwanto; J Donald Ostrow; Claudio Tiribelli
Journal:  BMC Res Notes       Date:  2010-06-09

7.  Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model.

Authors:  Folke Freudenberg; Annemarie L Broderick; Bian B Yu; Monika R Leonard; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

Review 8.  Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.

Authors:  Sanjiv B Amin; Tristram Smith; Geralyn Timler
Journal:  Pediatr Res       Date:  2018-10-23       Impact factor: 3.756

9.  A transcriptome analysis identifies molecular effectors of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells.

Authors:  Raffaella Calligaris; Cristina Bellarosa; Rossana Foti; Paola Roncaglia; Pablo Giraudi; Helena Krmac; Claudio Tiribelli; Stefano Gustincich
Journal:  BMC Genomics       Date:  2009-11-19       Impact factor: 3.969

10.  In vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells.

Authors:  Christine Mölzer; Barbara Pfleger; Elisabeth Putz; Antonia Roßmann; Ursula Schwarz; Marlies Wallner; Andrew C Bulmer; Karl-Heinz Wagner
Journal:  Exp Cell Res       Date:  2012-12-13       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.